Last reviewed · How we verify

NCT03744299: ACTIVATE

The Interest of Cancer Patients and Caregivers in Acupuncture: a Survey

Completed NA Last updated 22 February 2019
What this trial tests

NA trial testing Questionnaire in Cancer in 182 participants. Completed in 27 November 2018.

Timeline
20 November 2018
Primary endpoint
26 November 2018
27 November 2018

Quick facts

Lead sponsorGeneral Hospital Groeninge
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposehealth services research
Enrollment182
Start date20 November 2018
Primary completion26 November 2018
Estimated completion27 November 2018
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

General Hospital Groeninge

Who can join

18 and older, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cancer and cancer treatments are accompanied by several possible side effects, such as nausea, hot flashes, fatigue, drowsiness, etc. Complementary and integrative therapies, such as acupuncture, could be used to manage these symptoms. The aim of this study for our research team is to have an idea of the interest of cancer patients and caregivers in acupuncture. This is a prospective, interventional study. Cancer patients and caregivers will be approached at the day care clinic by a health care worker to participate in this study. They will be asked to complete a questionnaire about their interest in acupuncture and their motivation, what symptoms they would need it for, where they would like this acupuncture to take place, whether they are willing to pay for it, and whether they would be interested in an information session about acupuncture.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Questionnaire

Trials testing the same drug.

Other recruiting trials for Cancer

Currently open trials in the same condition.

Other General Hospital Groeninge trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03744299.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing